JILLIAN CHAMPION: Open Payments
NPI 1871092601 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 49 payments from 12 companies in 2025. Trend: 2023 $121 · 2024 $770 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $212 |
| ABBVIE INC. | 19 | $199 |
| Phathom Pharmaceuticals, Inc. | 2 | $134 |
| PFIZER INC. | 6 | $101 |
| Novo Nordisk Inc | 5 | $82 |
| Exact Sciences Corporation | 5 | $77 |
| Lilly USA, LLC | 4 | $68 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: VRAYLAR, VOQUEZNA, BREZTRI, FARXIGA, ELIQUIS, Ozempic, Cologuard Collection Kit, MOUNJARO.
Industry payments across KY — which companies pay providers there.
